CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
CLR01 is a molecular tweezer that inhibits protein aggregation. Here the authors show that CLR01 protects dopaminergic neurons in vitro and in vivo in human neurons and in mouse models showing potential as a disease-modifying therapy for Parkinson’s disease.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dbb405cbb99f4bdb826102e5b534b7da |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:dbb405cbb99f4bdb826102e5b534b7da |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:dbb405cbb99f4bdb826102e5b534b7da2021-12-02T17:18:08ZCLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease10.1038/s41467-020-18689-x2041-1723https://doaj.org/article/dbb405cbb99f4bdb826102e5b534b7da2020-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-18689-xhttps://doaj.org/toc/2041-1723CLR01 is a molecular tweezer that inhibits protein aggregation. Here the authors show that CLR01 protects dopaminergic neurons in vitro and in vivo in human neurons and in mouse models showing potential as a disease-modifying therapy for Parkinson’s disease.Nora Bengoa-VergnioryEmilie FaggianiPaula Ramos-GonzalezEcem KirkizNatalie Connor-RobsonLiam V. BrownIbrar SiddiqueZizheng LiSiv VingillMilena CiorochFabio CavaliereSarah ThrelfellBradley RobertsThomas SchraderFrank-Gerrit KlärnerStephanie CraggBenjamin DehayGal BitanCarlos MatuteErwan BezardRichard Wade-MartinsNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-14 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Nora Bengoa-Vergniory Emilie Faggiani Paula Ramos-Gonzalez Ecem Kirkiz Natalie Connor-Robson Liam V. Brown Ibrar Siddique Zizheng Li Siv Vingill Milena Cioroch Fabio Cavaliere Sarah Threlfell Bradley Roberts Thomas Schrader Frank-Gerrit Klärner Stephanie Cragg Benjamin Dehay Gal Bitan Carlos Matute Erwan Bezard Richard Wade-Martins CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease |
description |
CLR01 is a molecular tweezer that inhibits protein aggregation. Here the authors show that CLR01 protects dopaminergic neurons in vitro and in vivo in human neurons and in mouse models showing potential as a disease-modifying therapy for Parkinson’s disease. |
format |
article |
author |
Nora Bengoa-Vergniory Emilie Faggiani Paula Ramos-Gonzalez Ecem Kirkiz Natalie Connor-Robson Liam V. Brown Ibrar Siddique Zizheng Li Siv Vingill Milena Cioroch Fabio Cavaliere Sarah Threlfell Bradley Roberts Thomas Schrader Frank-Gerrit Klärner Stephanie Cragg Benjamin Dehay Gal Bitan Carlos Matute Erwan Bezard Richard Wade-Martins |
author_facet |
Nora Bengoa-Vergniory Emilie Faggiani Paula Ramos-Gonzalez Ecem Kirkiz Natalie Connor-Robson Liam V. Brown Ibrar Siddique Zizheng Li Siv Vingill Milena Cioroch Fabio Cavaliere Sarah Threlfell Bradley Roberts Thomas Schrader Frank-Gerrit Klärner Stephanie Cragg Benjamin Dehay Gal Bitan Carlos Matute Erwan Bezard Richard Wade-Martins |
author_sort |
Nora Bengoa-Vergniory |
title |
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease |
title_short |
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease |
title_full |
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease |
title_fullStr |
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease |
title_full_unstemmed |
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease |
title_sort |
clr01 protects dopaminergic neurons in vitro and in mouse models of parkinson’s disease |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/dbb405cbb99f4bdb826102e5b534b7da |
work_keys_str_mv |
AT norabengoavergniory clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT emiliefaggiani clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT paularamosgonzalez clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT ecemkirkiz clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT natalieconnorrobson clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT liamvbrown clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT ibrarsiddique clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT zizhengli clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT sivvingill clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT milenacioroch clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT fabiocavaliere clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT sarahthrelfell clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT bradleyroberts clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT thomasschrader clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT frankgerritklarner clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT stephaniecragg clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT benjamindehay clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT galbitan clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT carlosmatute clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT erwanbezard clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease AT richardwademartins clr01protectsdopaminergicneuronsinvitroandinmousemodelsofparkinsonsdisease |
_version_ |
1718381172039352320 |